Loading clinical trials...
Loading clinical trials...
A Multicenter Prospective Randomized Study to Evaluate the Efficacy of Apixaban and Clopidogrel on the Prevention of Recurrent Ischemic Stroke in Patients With Atrial Fibrillation and Cerebral Atherosclerosis
Conditions
Interventions
Apixaban
Clopidogrel
Start Date
December 1, 2025
Primary Completion Date
July 1, 2029
Completion Date
October 1, 2029
Last Updated
November 19, 2025
NCT06258538
NCT07371455
NCT05093673
NCT07253181
NCT06870812
NCT05147792
Lead Sponsor
Yonsei University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions